glp-1 receptor activation Agonists as Treatments for Type 2 Diabetes GLP-1 Receptor Agonists | New

Identification and functional analysis of mutations in FAD-binding domain of mitochondrial glycerophosphate dehydrogenase in caucasian patients with type 2 diabetes mellitus

GIP mediates the metabolic effect of corticosterone (Bates et al

The generics, now available in pharmacies with a prescription, will cost 3,500-4,500

Jae Hyung Park (Sungkyunkwan University, Republic of Korea) and his colleagues have developed a tumor-targeted, bioreducible nanoparticle system that can deliver cytotoxic anticancer drugs to tumor tissues and release the drugs inside cancer cells in response to the intracellular molecule glutathione

ICH Q3A(R2) describes general impurity categories for chemically synthesized substances, and ICH Q3C(R9) describes the control of residual solvents